Not Just Sick Enough to Sell To
Culture Critique / Reframing
We’re told we’re living in an age of medical miracles. And in many ways, we are.
But we’re also living in a time when tens of thousands of cannabis patients in the UK—people managing chronic pain, cancer, epilepsy, and anxiety—are still navigating a fragmented, underfunded system that doesn't fully believe they exist.
Meanwhile, opioids remain widely prescribed.
Globally, opioids kill more than 120,000 people every year—a number that keeps rising despite everything we know about alternatives like cannabis.
Addiction and dependency aren’t abstract—they’re quietly stitched into everyday medicine.
Cannabis isn’t the enemy. It’s an opportunity.
There are over 63,000 active medical cannabis patients in the UK (2024), and over 1.8 million who use cannabis from the unregulated market for symptom relief.
The evidence is growing: cannabis helps.
It doesn’t replace chemotherapy, but it can help patients sleep. Eat. Stabilise.
It doesn’t erase trauma, but it can turn the volume down long enough to function.
And yet—95% of prescriptions in the UK are filled by foreign suppliers.
We export cannabis. We import product.
We regulate in circles while patients suffer in silence.
What’s missing isn’t belief. It’s infrastructure.
This isn’t about whether cannabis works.
This is about whether the UK is prepared to support it properly.
And right now, we aren’t.
No widely accessible domestic supply chain.
No funding for trial-ready facilities.
No fast-track routes for ethical R&D.
No cultural infrastructure for this new class of patient-professional.
This is where Business Casual comes in.
We’re not a fashion label.
We’re a funding mechanism in disguise.
Every Founder Drop—starting with Drop 001—sends 100% of profits to build the infrastructure needed to support cannabis research, controlled storage, and licensing in the UK.
The first facility is being scoped between Edinburgh and Glasgow.
It’s designed to hold, study, and distribute controlled substances like cannabis for real medical use—not just theory.
We’re not guessing.
We’re working with researchers, reviewing Home Office requirements, running site visits, and speaking with NHS-aligned partners.
This Isn’t Charity. It’s Correction.
Modern medicine is a miracle.
But modern pharma has also built a business model on the back of people being just sick enough to need more.
We believe in something else:
That the business model can also serve health.
That cannabis, psychedelics, and AI-driven education platforms can be funded from culture, not pharma profits.
That style and science can work together, if built with discipline.
And that progress isn’t just passing a bill.
It’s giving people access, legally, securely, and with dignity.
It’s Time to Change What Business Looks Like
The UK has a chance right now to lead—not react.
We can build better rituals.
Better defaults.
Better systems that help cannabis become what it already is for many people: a tool for balance, not escape.
That’s what Business Casual is funding.
One hoodie at a time. One license at a time. One research facility at a time.
Not for hype.
Not for trend.
But because no one else will.
Subscribe to follow the work behind Drop 001. This isn’t merch. It’s infrastructure.
#BusinessCasual #FundTheFuture #MedicalCannabisUK #FounderDrop001 #BuildTheBridge